These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4892234)

  • 1. The influence of human serum on the anti-tumour activity of two L-asparaginases.
    Lee MB; Niblock RM; Bridges JM
    Br J Cancer; 1969 Jun; 23(2):369-76. PubMed ID: 4892234
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental investigations on problems of the clinical use of L-asparaginase.
    Bierling R
    Recent Results Cancer Res; 1970; 33():114-24. PubMed ID: 4115400
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
    Adamson RH; Fabro S
    Cancer Chemother Rep; 1968 Oct; 52(6):617-26. PubMed ID: 4895425
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
    Roberts J; Schmid FA; Old LJ; Stockert E
    Cancer Biochem Biophys; 1976 May; 1(4):175-8. PubMed ID: 788892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electron microscopic observations on the effect of L-asparaginase at transplanted leukemias of the mouse].
    Voigt WH; Grundmann E; Bierling R
    Beitr Pathol Anat; 1970; 140(2):237-55. PubMed ID: 5418958
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of L-asparaginase preparations of E. coli and agouti serum on the homograft reactivity in the mouse.
    Schulten HK; Giraldo G
    Recent Results Cancer Res; 1970; 33():155-9. PubMed ID: 4949159
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on neutralization of L-asparaginase activity in vitro and in vivo.
    Vadlamudi S; Padarathsingh M; Bonmassar E; Waravdekar V; Goldin A
    Cancer; 1971 Jun; 27(6):1321-7. PubMed ID: 4996690
    [No Abstract]   [Full Text] [Related]  

  • 10. L-asparagine and leukemia.
    Old LJ; Boyse EA; Campbell HA
    Sci Am; 1968 Aug; 219(2):34-40. PubMed ID: 4874838
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
    Jacobs SP; Wodinsky I; Kensler CJ; Venditti JM
    Cancer Chemother Rep; 1970 Oct; 54(5):329-35. PubMed ID: 5514622
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical influence of an enzyme-elevating virus upon long-term remissions of mouse leukemia following asparaginase therapy.
    Riley V; Spackman DH; Fitzmaurice MA
    Recent Results Cancer Res; 1970; 33():81-101. PubMed ID: 4949171
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase.
    Boyse EA; Old LJ; Campbell HA; Mashburn LT
    J Exp Med; 1967 Jan; 125(1):17-31. PubMed ID: 5334543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antineoplastic effect of L-asparaginase].
    Opolski A
    Postepy Hig Med Dosw; 1981; 35(2):177-87. PubMed ID: 7038650
    [No Abstract]   [Full Text] [Related]  

  • 15. Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.
    Vadlamudi S; Krishna B; Reddy VV; Goldin A
    Cancer Res; 1973 Sep; 33(9):2014-9. PubMed ID: 4725366
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of succinylated Acinetobacter glutaminase-asparaginase treatment on an acute myeloid leukemia in the rat (BNML).
    Sonneveld P; Holcenberg JS; van Bekkum DW
    Eur J Cancer (1965); 1979 Aug; 15(8):1061-3. PubMed ID: 292598
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of endotoxin in commercial L-asparaginase preparations by complement fixation and separation by chromatography.
    Loos M; Vadlamudi S; Meltzer M; Shifrin S; Borsos T; Goldin A
    Cancer Res; 1972 Nov; 32(11):2292-6. PubMed ID: 4563138
    [No Abstract]   [Full Text] [Related]  

  • 18. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
    Broome JD
    Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates.
    Abuchowski A; Kazo GM; Verhoest CR; Van Es T; Kafkewitz D; Nucci ML; Viau AT; Davis FF
    Cancer Biochem Biophys; 1984 Jun; 7(2):175-86. PubMed ID: 6467175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of E.coli-L-asparaginase alone or in combination with INH or PAS on the course of experimental tuberculosis in guinea pigs].
    Schwartz E; Badalík L
    Bratisl Lek Listy; 1972 Dec; 58(6):697-707. PubMed ID: 4568899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.